Given the growing body of evidence that supports the expression of HSPs as therapeutic targets for Alzheimer’s and Parkinson’s diseases (section “Heat Shock Proteins As a Therapeutic Target”), there is a clear need for future investigations of passive heating to monitor thermoregulation and HSP responses in people with these neurodegenerative diseases. This evidence concerns the gene HSP90B2P and Parkinson disease.